- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Corneal topography.
Displaying page 1 of 1.
EudraCT Number: 2007-006024-35 | Sponsor Protocol Number: cysteamine gel formulation/07/cysta | Start Date*: 2008-02-04 | |||||||||||
Sponsor Name:Orphan Europe SARL | |||||||||||||
Full Title: Adaptive dose regimen of Cystadrops for cOrneal Crystal deposiTs and ocular manifestations in nephropathic cystinosis : an open label, dose-response pilot study | |||||||||||||
Medical condition: Nephropathic cystinotic patients with cystine crystals corneal deposits | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000348-26 | Sponsor Protocol Number: UVA/B2 | Start Date*: 2006-05-17 |
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | ||
Full Title: A randomised prospective study to investigate the efficacy of corneal collagen cross-linkage with riboflavin (vitamin B2) and ultraviolet A light (UVA) (370nm) to halt the progression of keratoconus. | ||
Medical condition: Keratoconus affects the young, presenting in adolescence with impaired vision. This distortion of vision is due to the forward bowing of the weakened cornea. This is thought to be due to a congenit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-000523-14 | Sponsor Protocol Number: EI17-00523 | Start Date*: 2021-11-26 | |||||||||||
Sponsor Name:Universidad Miguel Hernandez | |||||||||||||
Full Title: Transplantation of autologous mesenchymal stem cells of adipose origin for the treatment of corneal diseases | |||||||||||||
Medical condition: Corneal Diseases | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001460-11 | Sponsor Protocol Number: 15/0599 | Start Date*: 2016-06-30 | |||||||||||
Sponsor Name:UCL CCTU | |||||||||||||
Full Title: Corneal cross-linking versus standard care in children with keratoconus, a randomised, multicentre, observer-masked trial of efficacy and safety | |||||||||||||
Medical condition: Patients with progressive keratoconus disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002046-16 | Sponsor Protocol Number: MARS_2020 | Start Date*: 2020-11-04 |
Sponsor Name:Fakultní nemocnice Brno | ||
Full Title: A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness)... | ||
Medical condition: Myopia in children | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002535-28 | Sponsor Protocol Number: 7343 | Start Date*: Information not available in EudraCT |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: Braking effect on myopia with atropine eye drops at 0.01%. | ||
Medical condition: Myopia | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003215-63 | Sponsor Protocol Number: 69HCL19_0032 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Hospices Civils de Lyon - Direction de la Recherche Clinique et de l'Innovation | |||||||||||||
Full Title: Cultured Autologous Oral Mucosa Epithelial sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency - FEMJA for « Feuillet Epithélial de Muqueuse Jugale Autologue » | |||||||||||||
Medical condition: Bilateral Limbal Stem Cell Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003556-31 | Sponsor Protocol Number: SHP-607-201 | Start Date*: 2015-02-10 |
Sponsor Name:Premacure AB, A Member of the Shire Group of Companies | ||
Full Title: Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care | ||
Medical condition: Retinopathy of Prematurity (ROP) | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) GB (GB - no longer in EU/EEA) NL (Completed) PL (Completed) IT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
